文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于生活方式干预的数字疗法在低密度脂蛋白胆固醇管理中的机遇与挑战:一项范围综述

Opportunities and challenges of lifestyle intervention-based digital therapeutics in LDL-C management: a scoping review.

作者信息

Tang Jia, Song Tiantian, Kuang Ming, Liu Hongying

机构信息

Hangzhou Kang Ming Information Technology Co., Ltd., Hangzhou, China.

Hangzhou Kang Sheng Health Consulting Co., Ltd., Hangzhou, China.

出版信息

Ther Adv Chronic Dis. 2025 May 14;16:20406223251334439. doi: 10.1177/20406223251334439. eCollection 2025.


DOI:10.1177/20406223251334439
PMID:40376548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12078976/
Abstract

BACKGROUND: In recent decades, the prevalence of dyslipidemia, especially high low-density lipoprotein cholesterol (LDL-C), has risen sharply in China. Although lifestyle interventions are important, traditional face-to-face approaches have limitations. Digital Therapeutics (DTx) can provide an effective solution by delivering remote medical interventions to patients via software and hardware, thereby optimizing existing clinical treatment methods with enhanced convenience and accessibility. OBJECTIVES: This study aims to explore the current evidence on the effect of lifestyle intervention-based Digital Therapeutics (LI-DTx) on high LDL-C, and to analyze their advantages and disadvantages. ELIGIBILITY CRITERIA: This scoping review examines clinical studies assessing the effects of DTx on LDL-C levels. Papers were included in the final analysis if there was evidence that DTx had effects on lowering LDL-C levels. SOURCES OF EVIDENCE: Papers that were published between January 2014 and December 2023 were included in the PubMed database. CHARTING METHODS: Data extracted from the publications included country, year, study type, study population, sample size, study duration, intervention, and changes in LDL-C level. RESULTS: A total of 23 target literature were identified. Twenty-one studies confirmed that LI-DTx could optimize the LDL-C level through remote lifestyle interventions such as diet, exercise, medication, and health education, of which 14 studies reported a significant reduction in LDL-C level ( < 0.05). In the future, the development and design of DTx will need to improve intelligence, personalization, applicability, real-time performance, and data security; integrate with traditional healthcare systems; facilitate multidisciplinary collaboration in dyslipidemia management; and enhance long-term patient engagement with DTx platforms. CONCLUSION: LI-DTx may offer a more effective and sustainable solution for LDL-C management, although several challenges remain. Further randomized controlled clinical trials are needed to provide scientific support for its efficacy and safety.

摘要

背景:近几十年来,中国血脂异常的患病率急剧上升,尤其是高低密度脂蛋白胆固醇(LDL-C)。尽管生活方式干预很重要,但传统的面对面方式存在局限性。数字疗法(DTx)可以通过软件和硬件为患者提供远程医疗干预,从而提供有效的解决方案,以增强便利性和可及性来优化现有的临床治疗方法。 目的:本研究旨在探讨基于生活方式干预的数字疗法(LI-DTx)对高LDL-C影响的现有证据,并分析其优缺点。 纳入标准:本范围综述审查评估DTx对LDL-C水平影响的临床研究。如果有证据表明DTx对降低LDL-C水平有影响,则将论文纳入最终分析。 证据来源:2014年1月至2023年12月期间发表的论文纳入PubMed数据库。 制表方法:从出版物中提取的数据包括国家、年份、研究类型、研究人群、样本量、研究持续时间、干预措施以及LDL-C水平的变化。 结果:共确定了23篇目标文献。21项研究证实,LI-DTx可以通过饮食、运动、药物治疗和健康教育等远程生活方式干预来优化LDL-C水平,其中14项研究报告LDL-C水平显著降低(<0.05)。未来,DTx的开发和设计需要提高智能性、个性化、适用性、实时性和数据安全性;与传统医疗系统整合;促进血脂异常管理中的多学科协作;并增强患者对DTx平台的长期参与度。 结论:LI-DTx可能为LDL-C管理提供更有效和可持续的解决方案,尽管仍存在一些挑战。需要进一步的随机对照临床试验为其疗效和安全性提供科学支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74f/12078976/6ca43f98c344/10.1177_20406223251334439-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74f/12078976/e07dfc816162/10.1177_20406223251334439-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74f/12078976/6ca43f98c344/10.1177_20406223251334439-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74f/12078976/e07dfc816162/10.1177_20406223251334439-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74f/12078976/6ca43f98c344/10.1177_20406223251334439-fig2.jpg

相似文献

[1]
Opportunities and challenges of lifestyle intervention-based digital therapeutics in LDL-C management: a scoping review.

Ther Adv Chronic Dis. 2025-5-14

[2]

2016-8

[3]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[4]
Digital therapeutics in hypertension: How to make sustainable lifestyle changes.

J Clin Hypertens (Greenwich). 2024-10

[5]
Benchmarking the clinical outcomes of Healthentia SaMD in chronic disease management: a systematic literature review comparison.

Front Public Health. 2024-12-24

[6]
Challenges With the Use of Digital Sham: Systematic Review and Recommendations.

J Med Internet Res. 2023-10-24

[7]
Effects on Adherence to a Mobile App-Based Self-management Digital Therapeutics Among Patients With Coronary Heart Disease: Pilot Randomized Controlled Trial.

JMIR Mhealth Uhealth. 2022-2-15

[8]
The future of Cochrane Neonatal.

Early Hum Dev. 2020-11

[9]
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.

Med J Aust. 2020-12

[10]

2016-8

引用本文的文献

[1]
Effects of 12 nutritional interventions on type 2 diabetes: a systematic review with network meta-analysis of randomized trials.

Nutr Metab (Lond). 2025-8-7

本文引用的文献

[1]
Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial.

J Med Internet Res. 2024-10-2

[2]
Effects of a patient-centered digital health intervention in patients referred to cardiac rehabilitation: the Smart HEART clinical trial.

BMC Cardiovasc Disord. 2023-9-12

[3]
Effect of cigarette smoking on smoking biomarkers, blood pressure and blood lipid levels among Sri Lankan male smokers.

Postgrad Med J. 2022-11-1

[4]
Effects of a smartphone app-based diet and physical activity program for men living with HIV who have dyslipidemia: A pilot randomized controlled trial.

Jpn J Nurs Sci. 2023-7

[5]
Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial.

J Med Internet Res. 2023-4-12

[6]
Harnessing digital health to optimise the delivery of guideline-based cardiac rehabilitation during COVID-19: an observational study.

Open Heart. 2023-3

[7]
[Chinese guidelines for lipid management (2023)].

Zhonghua Xin Xue Guan Bing Za Zhi. 2023-3-24

[8]
Effects of a digital diabetes prevention program on cardiovascular risk among individuals with prediabetes.

Prim Care Diabetes. 2023-4

[9]
Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial.

Am J Gastroenterol. 2023-8-1

[10]
Effect of cognitive behavior therapy (CBT) on lowering of blood glucose levels in gestational diabetes mellitus (GDM) patients: study protocol for a prospective, open-label, randomized controlled trial.

Trials. 2023-1-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索